Search results
The Mexico City Principles are voluntary guidance for ethical business conduct in the biopharmaceutical sector with government and multi-stakeholder recognition. They cover six principles of healthcare and patient focus, integrity, independence, legitimate intent, transparency, and accountability.
The Mexico City Principles are a set of voluntary codes of business ethics for companies in the biopharmaceutical sector. They aim to ensure ethical interactions with healthcare professionals and other stakeholders, and to promote patient-focused and transparent practices.
The APEC Mexico City Principles are the world’s only voluntary guidance for ethical business conduct in the biopharmaceutical sector. Learn how they will be updated in 2021 to reflect the latest standards and stakeholder roles.
“The Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector” (Annex 1) shall be implemented pursuant to the provision of R.A. No. 9711, also known as the “FDA Act of 2009”, in Section 4.0., which mandates FDA to prescribe standards, guidelines, and regulations with respect to information ...
To avoid these unnecessary impediments to the growth of the Biopharmaceutical Sector, The Mexico City Principles was created with the aim to: significantly reduce ethics compliance costs for SMEs by providing greater clarity and a collective understanding of what constitutes appropriate interactions with healthcare professionals to increase the ...
The Mexico City Principles. For Voluntary Codes of Business Ethics in the Biopharmaceutical Sector. Ethical interactions help ensure that medical decisions are made in the best interests of patients.
The Mexico City Principles are a set of voluntary codes of business ethics for companies in the biopharmaceutical sector. They aim to ensure ethical interactions with healthcare professionals and other stakeholders, and to promote patient-focused and transparent practices.
